These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16790921)

  • 1. Magnetic resonance spectroscopy (MRS) in the investigation of cancer at The Royal Marsden Hospital and The Institute of Cancer Research.
    Leach MO
    Phys Med Biol; 2006 Jul; 51(13):R61-82. PubMed ID: 16790921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy.
    Prost RW
    Med Phys; 2008 Oct; 35(10):4530-44. PubMed ID: 18975700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hierarchical unsupervised spectral clustering scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).
    Tiwari P; Madabhushi A; Rosen M
    Med Image Comput Comput Assist Interv; 2007; 10(Pt 2):278-86. PubMed ID: 18044579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR spectroscopy of head and neck cancer.
    Abdel Razek AA; Poptani H
    Eur J Radiol; 2013 Jun; 82(6):982-9. PubMed ID: 23485098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Localized nuclear magnetic resonance spectroscopy in vivo. Physical principles and quantitative problems].
    Canese R; Podo F
    Ann Ist Super Sanita; 1991; 27(4):675-708. PubMed ID: 1820740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of evidence-based medicine on magnetic resonance spectroscopy.
    Lin AP; Tran TT; Ross BD
    NMR Biomed; 2006 Jun; 19(4):476-83. PubMed ID: 16763969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts.
    Kreis R
    NMR Biomed; 2004 Oct; 17(6):361-81. PubMed ID: 15468083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimension reduction-based penalized logistic regression for cancer classification using microarray data.
    Shen L; Tan EC
    IEEE/ACM Trans Comput Biol Bioinform; 2005; 2(2):166-75. PubMed ID: 17044181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer biomarkers: a systems approach.
    Hartwell L; Mankoff D; Paulovich A; Ramsey S; Swisher E
    Nat Biotechnol; 2006 Aug; 24(8):905-8. PubMed ID: 16900126
    [No Abstract]   [Full Text] [Related]  

  • 10. 13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C-labeled glutamine.
    Gallagher FA; Kettunen MI; Day SE; Lerche M; Brindle KM
    Magn Reson Med; 2008 Aug; 60(2):253-7. PubMed ID: 18666104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo magnetic resonance spectroscopy in cancer.
    Gillies RJ; Morse DL
    Annu Rev Biomed Eng; 2005; 7():287-326. PubMed ID: 16004573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological standardization for a multi-institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies.
    Arias-Mendoza F; Zakian K; Schwartz A; Howe FA; Koutcher JA; Leach MO; Griffiths JR; Heerschap A; Glickson JD; Nelson SJ; Evelhoch JL; Charles HC; Brown TR;
    NMR Biomed; 2004 Oct; 17(6):382-91. PubMed ID: 15386624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant transformation: the role of MRS.
    Jiang L; Wijnen JP; Glunde K
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S66-8. PubMed ID: 23083608
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo 31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial.
    Arias-Mendoza F; Payne GS; Zakian KL; Schwarz AJ; Stubbs M; Stoyanova R; Ballon D; Howe FA; Koutcher JA; Leach MO; Griffiths JR; Heerschap A; Glickson JD; Nelson SJ; Evelhoch JL; Charles HC; Brown TR
    NMR Biomed; 2006 Jun; 19(4):504-12. PubMed ID: 16763965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
    Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
    NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.
    Villeirs GM; Oosterlinck W; Vanherreweghe E; De Meerleer GO
    Eur J Radiol; 2010 Feb; 73(2):352-6. PubMed ID: 19084363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding discriminative subtypes of aggressive brain tumours using magnetic resonance spectroscopy.
    Colas F; Kok JN; Vellido A
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():1065-8. PubMed ID: 21096552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Applications of 1H nuclear magnetic resonance spectroscopy and nuclear magnetic resonance-based metabonomics in tumour studies].
    Gao HC; Lin DH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):803-10. PubMed ID: 18595263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain imaging developments based on in vivo MRS.
    Chen W
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():50-2. PubMed ID: 19965111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging tumor metabolism using in vivo magnetic resonance spectroscopy.
    Li Y; Park I; Nelson SJ
    Cancer J; 2015; 21(2):123-8. PubMed ID: 25815853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.